These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20720461)

  • 1. Pharmaceutical reduction of breast cancer risk.
    Simmons S
    Nurse Pract; 2010 Sep; 35(9):10-1. PubMed ID: 20720461
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal breast cancer agents: implications for the primary care provider.
    Lyon DE; Roux G; Voll S
    J Am Acad Nurse Pract; 2006 Nov; 18(11):518-23. PubMed ID: 17064329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen versus aromatase inhibitors for breast cancer prevention.
    Yue W; Wang JP; Li Y; Bocchinfuso WP; Korach KS; Devanesan PD; Rogan E; Cavalieri E; Santen RJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):925s-30s. PubMed ID: 15701888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing endocrine therapy for breast cancer.
    Winer EP
    J Clin Oncol; 2005 Mar; 23(8):1609-10. PubMed ID: 15755964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aromatase inhibitors in risk reduction of breast cancer: potential use in premenopausal women].
    Kubatka P; Péc M
    Klin Onkol; 2009; 22(6):268-72. PubMed ID: 20099744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving role of endocrine therapy for the treatment and prevention of breast cancer.
    Gradishar WJ; Jordan VC
    Cancer Chemother Biol Response Modif; 2002; 20():227-38. PubMed ID: 12703207
    [No Abstract]   [Full Text] [Related]  

  • 7. Does raloxifene reduce breast cancer risk?
    Mattimoe D; Newton W
    J Fam Pract; 1999 Sep; 48(9):659-60. PubMed ID: 10498063
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body.
    Gadducci A; Cosio S; Genazzani AR
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1031-44. PubMed ID: 15535424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen Breast Cancer Prevention Trial--an update.
    Ford LG; Johnson KA
    Prog Clin Biol Res; 1997; 396():271-82. PubMed ID: 9108604
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine therapy for breast cancer: an overview.
    Cheung KL
    Breast; 2007 Aug; 16(4):327-43. PubMed ID: 17499991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.
    Labrie F
    Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):584-93. PubMed ID: 17643129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of hormone-related cancers: breast cancer.
    Dunn BK; Wickerham DL; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprevention for breast cancers].
    Lanng C
    Ugeskr Laeger; 2007 Sep; 169(36):2975-6. PubMed ID: 17953872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aromatase inhibitors--new applications in gynecology].
    Shrim A; Elizur SE; Beiner ME; Wiser A; Seidman DS
    Harefuah; 2004 Aug; 143(8):580-4, 622. PubMed ID: 15523811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel concepts for the chemoprevention of breast cancer through aromatase inhibition.
    Kendall A; Dowsett M
    Endocr Relat Cancer; 2006 Sep; 13(3):827-37. PubMed ID: 16954432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-hormonal therapy in breast cancer].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical pharmacology of targeted drug for breast cancer].
    Ishiguro H; Saji S; Toi M
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():443-6. PubMed ID: 23513881
    [No Abstract]   [Full Text] [Related]  

  • 19. Introduction to the conference, Aromatase: New Perspectives for Breast Cancer.
    Santen RJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3268s. PubMed ID: 7083183
    [No Abstract]   [Full Text] [Related]  

  • 20. Aromatase inhibitors for breast cancer prevention.
    Cuzick J
    J Clin Oncol; 2005 Mar; 23(8):1636-43. PubMed ID: 15755971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.